Estland - Estlands - Ravimiamet

pharmaswiss ceska republika s.r.o. - imatiniib - õhukese polümeerikattega tablett - 100mg 60tk

Estland - Estlands - Ravimiamet

apotex europe b.v. - imatiniib - õhukese polümeerikattega tablett - 400mg 30tk

Europese Unie - Estlands - EMA (European Medicines Agency)

kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - lümfoom, mantle-cell - antineoplastilised ained - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor. acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).

Europese Unie - Estlands - EMA (European Medicines Agency)

novartis europharm limited - tisagenlecleucel - precursor b-cell lymphoblastic leukemia-lymphoma; lymphoma, large b-cell, diffuse - muud antineoplastilised ained - kymriah is indicated for the treatment of:• paediatric and young adult patients up to and including 25 years of age with b cell acute lymphoblastic leukaemia (all) that is refractory, in relapse post transplant or in second or later relapse. • adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl) after two or more lines of systemic therapy. • adult patients with relapsed or refractory follicular lymphoma (fl) after two or more lines of systemic therapy.

Estland - Estlands - Ravimiamet

oÜ baxter estonia - mitoksantroon - infusioonilahuse kontsentraat - 2mg 1ml 5ml 1tk; 2mg 1ml 10ml 1tk; 2mg 1ml 15ml 1tk; 2mg 1ml 12.5ml 1tk

Estland - Estlands - Ravimiamet

zentiva k.s. - imatiniib - õhukese polümeerikattega tablett - 400mg 20tk; 400mg 180tk; 400mg 60tk; 400mg 120tk

Estland - Estlands - Ravimiamet

krka, d.d., novo mesto - imatiniib - õhukese polümeerikattega tablett - 400mg 90tk; 400mg 10tk; 400mg 30tk

Estland - Estlands - Ravimiamet

sandoz pharmaceuticals d.d. - imatiniib - õhukese polümeerikattega tablett - 100mg 60tk; 100mg 30tk; 100mg 120tk; 100mg 20tk; 100mg 80tk; 100mg 90tk; 100mg 50tk

Estland - Estlands - Ravimiamet

zentiva k.s. - imatiniib - õhukese polümeerikattega tablett - 100mg 180tk; 100mg 120tk; 100mg 10tk; 100mg 30tk; 100mg 90tk; 100mg 20tk

Estland - Estlands - Ravimiamet

norameda uab - imatiniib - kõvakapsel - 400mg 100tk; 400mg 30tk; 400mg 10tk; 400mg 90tk